Literature DB >> 22033924

Molecular determinants of ivermectin sensitivity at the glycine receptor chloride channel.

Timothy Lynagh1, Timothy I Webb1, Christine L Dixon1, Brett A Cromer2, Joseph W Lynch3.   

Abstract

Ivermectin is an anthelmintic drug that works by activating glutamate-gated chloride channel receptors (GluClRs) in nematode parasites. GluClRs belong to the Cys-loop receptor family that also includes glycine receptor (GlyR) chloride channels. GluClRs and A288G mutant GlyRs are both activated by low nanomolar ivermectin concentrations. The crystal structure of the Caenorhabditis elegans α GluClR complexed with ivermectin has recently been published. Here, we probed ivermectin sensitivity determinants on the α1 GlyR using site-directed mutagenesis and electrophysiology. Based on a mutagenesis screen of transmembrane residues, we identified Ala288 and Pro230 as crucial sensitivity determinants. A comparison of the actions of selamectin and ivermectin suggested the benzofuran C05-OH was required for high efficacy. When taken together with docking simulations, these results supported a GlyR ivermectin binding orientation similar to that seen in the GluClR crystal structure. However, whereas the crystal structure shows that ivermectin interacts with the α GluClR via H-bonds with Leu218, Ser260, and Thr285 (α GluClR numbering), our data indicate that H-bonds with residues homologous to Ser260 and Thr285 are not important for high ivermectin sensitivity or direct agonist efficacy in A288G α1 GlyRs or three other GluClRs. Our data also suggest that van der Waals interactions between the ivermectin disaccharide and GlyR M2-M3 loop residues are unimportant for high ivermectin sensitivity. Thus, although our results corroborate the ivermectin binding orientation as revealed by the crystal structure, they demonstrate that some of the binding interactions revealed by this structure do not pertain to other highly ivermectin-sensitive Cys-loop receptors.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22033924      PMCID: PMC3243547          DOI: 10.1074/jbc.M111.262634

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  45 in total

1.  Drug-resistant Drosophila indicate glutamate-gated chloride channels are targets for the antiparasitics nodulisporic acid and ivermectin.

Authors:  N S Kane; B Hirschberg; S Qian; D Hunt; B Thomas; R Brochu; S W Ludmerer; Y Zheng; M Smith; J P Arena; C J Cohen; D Schmatz; J Warmke; D F Cully
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

2.  A glycine residue essential for high ivermectin sensitivity in Cys-loop ion channel receptors.

Authors:  Timothy Lynagh; Joseph W Lynch
Journal:  Int J Parasitol       Date:  2010-08-14       Impact factor: 3.981

Review 3.  Molecular pharmacology of the glycine receptor chloride channel.

Authors:  Timothy I Webb; Joseph W Lynch
Journal:  Curr Pharm Des       Date:  2007       Impact factor: 3.116

Review 4.  Binding, activation and modulation of Cys-loop receptors.

Authors:  Paul S Miller; Trevor G Smart
Journal:  Trends Pharmacol Sci       Date:  2010-01-25       Impact factor: 14.819

5.  Loop 2 structure in glycine and GABA(A) receptors plays a key role in determining ethanol sensitivity.

Authors:  Daya I Perkins; James R Trudell; Daniel K Crawford; Liana Asatryan; Ronald L Alkana; Daryl L Davies
Journal:  J Biol Chem       Date:  2009-08-05       Impact factor: 5.157

6.  The surface accessibility of the glycine receptor M2-M3 loop is increased in the channel open state.

Authors:  J W Lynch; N L Han; J Haddrill; K D Pierce; P R Schofield
Journal:  J Neurosci       Date:  2001-04-15       Impact factor: 6.167

7.  An investigation of persistent microfilaridermias despite multiple treatments with ivermectin, in two onchocerciasis-endemic foci in Ghana.

Authors:  K Awadzi; D A Boakye; G Edwards; N O Opoku; S K Attah; M Y Osei-Atweneboana; J K Lazdins-Helds; A E Ardrey; E T Addy; B T Quartey; K Ahmed; B A Boatin; E W Soumbey-Alley
Journal:  Ann Trop Med Parasitol       Date:  2004-04

8.  Insights into the structural basis for zinc inhibition of the glycine receptor.

Authors:  Simon T Nevin; Brett A Cromer; Justine L Haddrill; Craig J Morton; Michael W Parker; Joseph W Lynch
Journal:  J Biol Chem       Date:  2003-05-09       Impact factor: 5.157

9.  Tryptophan substitutions reveal the role of nicotinic acetylcholine receptor alpha-TM3 domain in channel gating: differences between Torpedo and muscle-type AChR.

Authors:  Manuel Navedo; Madeline Nieves; Legier Rojas; Jose A Lasalde-Dominicci
Journal:  Biochemistry       Date:  2004-01-13       Impact factor: 3.162

10.  Genetic selection of low fertile Onchocerca volvulus by ivermectin treatment.

Authors:  Catherine Bourguinat; Sébastien D S Pion; Joseph Kamgno; Jacques Gardon; Brian O L Duke; Michel Boussinesq; Roger K Prichard
Journal:  PLoS Negl Trop Dis       Date:  2007-08-30
View more
  25 in total

1.  Propofol modulation of α1 glycine receptors does not require a structural transition at adjacent subunits that is crucial to agonist-induced activation.

Authors:  Timothy Lynagh; Alexander Kunz; Bodo Laube
Journal:  ACS Chem Neurosci       Date:  2013-09-17       Impact factor: 4.418

2.  Distinct properties of glycine receptor β+/α- interface: unambiguously characterizing heteromeric interface reconstituted in homomeric protein.

Authors:  Qiang Shan; Lu Han; Joseph W Lynch
Journal:  J Biol Chem       Date:  2012-04-25       Impact factor: 5.157

Review 3.  Glutamate-gated chloride channels.

Authors:  Adrian J Wolstenholme
Journal:  J Biol Chem       Date:  2012-10-04       Impact factor: 5.157

Review 4.  Inhibitory glycine receptors: an update.

Authors:  Sébastien Dutertre; Cord-Michael Becker; Heinrich Betz
Journal:  J Biol Chem       Date:  2012-10-04       Impact factor: 5.157

5.  A predicted binding site for cholesterol on the GABAA receptor.

Authors:  Jérôme Hénin; Reza Salari; Sruthi Murlidaran; Grace Brannigan
Journal:  Biophys J       Date:  2014-05-06       Impact factor: 4.033

Review 6.  Chemogenetic Tools for Causal Cellular and Neuronal Biology.

Authors:  Deniz Atasoy; Scott M Sternson
Journal:  Physiol Rev       Date:  2018-01-01       Impact factor: 37.312

7.  Positive allosteric modulation by ivermectin of human but not murine P2X7 receptors.

Authors:  W Nörenberg; H Sobottka; C Hempel; T Plötz; W Fischer; G Schmalzing; M Schaefer
Journal:  Br J Pharmacol       Date:  2012-09       Impact factor: 8.739

Review 8.  Chemogenetics as a neuromodulatory approach to treating neuropsychiatric diseases and disorders.

Authors:  Jingwei Song; Ruchit V Patel; Massoud Sharif; Anagha Ashokan; Michael Michaelides
Journal:  Mol Ther       Date:  2021-12-01       Impact factor: 11.454

9.  Stabilization of the GluCl ligand-gated ion channel in the presence and absence of ivermectin.

Authors:  Ozge Yoluk; Torben Brömstrup; Edward J Bertaccini; James R Trudell; Erik Lindahl
Journal:  Biophys J       Date:  2013-08-06       Impact factor: 4.033

10.  A nicotinic acetylcholine receptor transmembrane point mutation (G275E) associated with resistance to spinosad in Frankliniella occidentalis.

Authors:  Alin M Puinean; Stuart J Lansdell; Toby Collins; Pablo Bielza; Neil S Millar
Journal:  J Neurochem       Date:  2013-01-13       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.